XML 86 R63.htm IDEA: XBRL DOCUMENT v3.22.4
INCENTIVE STOCK PLANS (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs
A summary of our stock-based compensation cost is presented below:
 202220212020
Selling and general expenses$10,767 $8,255 $6,839 
Cost of sales1,226 816 693 
Timber and Timberlands, net (a)363 206 170 
Other operating expense, net (b)— — 324 
Total stock-based compensation$12,356 $9,277 $8,026 
Tax benefit recognized related to stock-based compensation expense (c)$603 $487 $421 
(a)Represents amounts capitalized as part of the overhead allocation of timber-related costs.
(b)Represents expense associated with the acceleration of share-based compensation on Pope replacement awards related to qualifying terminations.
(c)A valuation allowance is recorded against the tax benefit recognized as we do not expect to be able to realize the benefit in the future.
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
A summary of our restricted stock is presented below:
202220212020
Restricted shares granted (a)22,800 22,140 100,452 
Weighted average price of restricted shares granted$38.60 $37.36 $23.15 
Intrinsic value of restricted stock outstanding (b)$620 $3,062 $4,666 
Grant date fair value of restricted stock vested2,478 3,121 2,755 
Cash used to purchase common shares from current and former employees to pay withholding tax requirements on restricted shares vested708 869 566 
(a)The year ended December 31, 2020 includes 69,176 replacement awards issued as a result of the merger with Pope Resources.
(b)Intrinsic value of restricted stock outstanding is based on the market price of the Company’s stock at December 31, 2022.
 2022
Number of
Shares
Weighted
Average Grant
Date Fair Value
Non-vested Restricted Shares at January 1,75,862 $29.29 
Granted22,800 38.60 
Vested (a)(78,607)31.52 
Cancelled(1,247)24.32 
Non-vested Restricted Shares at December 31,18,808 $31.58 
(a)The year ended December 31, 2022 includes 3,718 replacement awards vested as a result of acceleration due to qualifying terminations.
A summary of our restricted stock units is presented below:
 202220212020
Restricted stock units granted130,213 129,290 171,409 
Weighted average price of restricted stock units granted$41.81 $33.59 $22.58 
Intrinsic value of restricted stock units outstanding (a)$13,826 $15,095 $7,801 
Grant date fair value of restricted stock units vested2,475 493 218 
Cash used to purchase common shares from current and former employees to pay withholding tax requirements on restricted stock units vested1,063 189 47 
(a)Intrinsic value of restricted stock units outstanding is based on the market price of the Company’s stock at December 31, 2022.
 2022
 Number of
Shares
Weighted
Average Grant
Date Fair Value
Non-vested Restricted Stock Units at January 1,374,016 $28.44 
Granted130,213 41.81 
Vested(80,857)30.61 
Cancelled(3,888)33.72 
Non-vested Restricted Stock Units at December 31,419,484 $32.12 
Schedule of Nonvested Performance-based Units Activity
A summary of our performance share units is presented below:
 202220212020
Common shares reserved for performance shares granted during year 193,333 191,203 361,870 
Weighted average fair value of performance share units granted$45.68 $36.10 $29.59 
Intrinsic value of outstanding performance share units (a)$13,123 $16,360 $11,711 
Fair value of performance shares vested5,549 1,738 3,522 
Cash used to purchase common shares from current and former employees to pay withholding tax requirements on performance shares vested2,454 559 992 
(a)Intrinsic value of outstanding performance share units is based on the market price of the Company's stock at December 31, 2022.
 2022
 Number
of Units
Weighted
Average Grant
Date Fair Value
Outstanding Performance Share units at January 1,405,361 $33.16 
Granted110,476 45.68 
Units Distributed(115,167)35.98 
Other Cancellations/Adjustments(2,514)39.23 
Outstanding Performance Share units at December 31,398,156 $35.78 
Expected volatility was estimated using daily returns on the Company’s common shares for the three-year period ending on the grant date. The risk-free rate was based on the 3-year U.S. Treasury rate on the date of the award. The dividend yield was not used to calculate fair value as awards granted receive dividend equivalents. Grants made to Vice Presidents and above are subject to a one-year post-vest holding period and include an additional discount for liquidity. The following table provides an overview of the assumptions used in calculating the fair value of the awards granted for the three years ended December 31:
 202220212020
Expected volatility38.1 %35.6 %32.6 %
Risk-free rate2.6 %0.4 %0.3 %
Liquidity discount applied to grants with a post-vesting holding restriction (a)4.2 %6.3 %n/a
 
(a)One-year post-vest holding requirement began in grant year 2021.
Schedule of Share-based Compensation, Stock Options, Activity
A summary of the status of our stock options as of and for the year ended December 31, 2022 is presented below:
 2022
 Number of
Shares
Weighted
Average Exercise
Price
(per common share)
Weighted
Average
Remaining
Contractual Term
(in years)
Aggregate
Intrinsic
Value
Options outstanding at January 1,124,170 $36.67 
Exercised(64,762)38.07 
Cancelled or expired(5,317)35.13 
Options outstanding at December 31,54,091 35.15 0.57$40 
Options exercisable at December 31,54,091 $35.15 0.57$40 
A summary of additional information pertaining to our stock options is presented below:
 202220212020
Intrinsic value of options exercised (a)$300 $916 $108 
Cash received from exercise of options2,466 5,922 1,368 
(a)Intrinsic value of options exercised is the amount by which the fair value of the stock on the exercise date exceeded the exercise price of the option.